GRIN1/NMDAR1 antibody
Quick Overview for GRIN1/NMDAR1 antibody (ABIN362999)
Target
See all GRIN1/NMDAR1 (GRIN1) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Specificity
- The antibody detects endogenous level of total Caveolin-2 protein.
-
Purification
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography usingepitope-specific immunogen.
-
Immunogen
- Antibodies were produced by immunizing rabbits with synthetic peptide and KLH conjugates. Antibodies were purified by affinity-chromatography using epitope-specific peptide.
-
Isotype
- IgG
-
-
-
-
Application Notes
- Western Blot: 1:500-1000
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Storage
- 4 °C/-20 °C
-
-
- GRIN1/NMDAR1 (GRIN1) (Glutamate Receptor, Ionotropic, N-Methyl D-Aspartate 1 (GRIN1))
-
Alternative Name
- NMDAR1
-
Background
- NMDA receptors are members of the ionotropic class of glutamate receptors, which also includes Kainate and AMPA receptors. NMDA receptors consist of NR1 subunits combined with one or more NR2 (A-D) or NR3 (A-B) subunits. The ligand-gated channel is permeable to cations including Ca2+, and at resting membrane potentials NMDA receptors are inactive due to a voltage-dependent blockade of the channel pore by Mg2+. NMDA receptor activation, which requires binding of glutamate and glycine, leads to an influx of Ca2+ into the postsynaptic region where it activates several signaling cascades, including pathways leading to the induction of long-term potentiation (LTP) and depression (LTD). NMDA receptors have a critical role in excitatory synaptic transmission and plasticity in the CNS. They govern a range of physiological conditions including neurological disorders caused by excitotoxic neuronal injury, psychiatric disorders and neuropathic pain syndromes.
-
Molecular Weight
- 22 kDa
-
Pathways
- Synaptic Membrane, Feeding Behaviour, Regulation of long-term Neuronal Synaptic Plasticity
Target
-